Censo Biotechnologies start 2017 with one of the busiest biotech weeks in the calendar as JP Morgan gathers together thousands of investors and executives from around the world to San Francisco from the 9th to 11th January.
Censo Biotechnologies, based at Roslin BioCentre, will be joining upwards of 2,800 attendees at the 9th Biotech Showcase, one of the life science industry’s largest conferences of the year.
This annual investor and networking conference provides private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place.
CEO, Aidan Courtney, and Head of Drug Discovery Services, Ashley Barnes, will be at Biotech Showcase looking to engage with businesses with iPSCs needs.
Censo Biotechnologies provides a bespoke end-to-end service for drug discovery, toxicity testing and cell banking. Our services include donor and cell sourcing, iPSC reprogramming, cell differentiation, phenotype identification, assay development and compound screening.